{ "story_id": "3f2f428e9468081459607f7c2f849163", "desk": "drm3", "revision": 1, "published_at": "2026-09-03T00:00:00.000Z", "content_hash": "eaa0dbf4f99e0b03c54d2a3c45b56d4588570affd038b8b5fba67574b9ace34f", "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs", "basis": { "headline": "Authorities Warn of Dangerous Fake Ozempic Sold Online", "dek": "Czech health officials warn of a lethal fake Ozempic batch containing unverified chemicals sold illegally online.", "prose": "Fake Ozempic pens sold online may not contain the active ingredient semaglutide but could instead contain completely different chemicals. [^1]\n\nThe Czech State Institute for Drug Control (SÚKL) warns that dangerous packaging for fake Ozempic injections has not yet appeared in official reports from licensed distributors but poses a risk from illegal online sales. [^2]\n\nResearch presented at the ENDO 2026 conference reported that people taking semaglutide for type 2 diabetes had a lower rate of bone fractures compared with those taking other anti-obesity medications. [^3]\n\nThe study data indicated that semaglutide treatment produced a greater reduction in body mass index and fewer fractures (794) than the control group (1045 fractures) among the type 2 diabetes patients analyzed. [^4]\n\nA retrospective observational cohort study was conducted on 12 adults with Prader-Willi syndrome at a UK academic hospital specialist clinic. [^5]\n\nResearchers found no significant overall weight loss on semaglutide, but there was a significant stabilization of weight gain prior to treatment. [^6]\n\nThere was a significant decrease in hyperphagia scores from the Hyperphagia Questionnaire for Clinical Trials with a p-value of 0.003. [^7]\n\nSemaglutide, a medication used for weight loss, has been introduced as a tablet in Germany, with plans for a similar launch in Austria. [^8]\n\nHistorical cases of similar fake injections have resulted in insulin shock for non-diabetics, causing severe hypoglycemia, convulsions, or unconsciousness. [^9]\n\nSome fake injection pens contain only non-sterile water, which can cause severe infections and sepsis after administration. [^10]\n\nJairo Noreña, MD, former endocrinology fellow at Stanford University Medical Center in Palo Alto, California, and colleagues evaluated changes in body mass index and fracture incidence in adults with type 2 diabetes taking semaglutide, dulaglutide, or the oral weight-loss drugs phentermine/topiramate and bupropion/naltrexone. [^11]\n\nThe study authors recommended that prospective studies be done to confirm the semaglutide bone-protective findings. [^12]", "cited": "[{\"statement\":\"Fake Ozempic pens sold online may not contain the active ingredient semaglutide but could instead contain completely different chemicals.\",\"source\":\"BLESK.cz\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:16:00.000Z\",\"publisher_count\":1,\"sources\":[\"BLESK.cz\"]},{\"statement\":\"The Czech State Institute for Drug Control (SÚKL) warns that dangerous packaging for fake Ozempic injections has not yet appeared in official reports from licensed distributors but poses a risk from illegal online sales.\",\"source\":\"BLESK.cz\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:16:00.000Z\",\"publisher_count\":1,\"sources\":[\"BLESK.cz\"]},{\"statement\":\"Research presented at the ENDO 2026 conference reported that people taking semaglutide for type 2 diabetes had a lower rate of bone fractures compared with those taking other anti-obesity medications.\",\"source\":\"Endocrine News\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:02:00.000Z\",\"publisher_count\":1,\"sources\":[\"Endocrine News\"]},{\"statement\":\"The study data indicated that semaglutide treatment produced a greater reduction in body mass index and fewer fractures (794) than the control group (1045 fractures) among the type 2 diabetes patients analyzed.\",\"source\":\"Endocrine News\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:02:00.000Z\",\"publisher_count\":1,\"sources\":[\"Endocrine News\"]},{\"statement\":\"A retrospective observational cohort study was conducted on 12 adults with Prader-Willi syndrome at a UK academic hospital specialist clinic.\",\"source\":\"Frontiers\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T00:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Frontiers\"]},{\"statement\":\"Researchers found no significant overall weight loss on semaglutide, but there was a significant stabilization of weight gain prior to treatment.\",\"source\":\"Frontiers\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T00:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Frontiers\"]},{\"statement\":\"There was a significant decrease in hyperphagia scores from the Hyperphagia Questionnaire for Clinical Trials with a p-value of 0.003.\",\"source\":\"Frontiers\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T00:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Frontiers\"]},{\"statement\":\"Semaglutide, a medication used for weight loss, has been introduced as a tablet in Germany, with plans for a similar launch in Austria.\",\"source\":\"DER STANDARD\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T10:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"DER STANDARD\"]},{\"statement\":\"Historical cases of similar fake injections have resulted in insulin shock for non-diabetics, causing severe hypoglycemia, convulsions, or unconsciousness.\",\"source\":\"BLESK.cz\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:16:00.000Z\",\"publisher_count\":1,\"sources\":[\"BLESK.cz\"]},{\"statement\":\"Some fake injection pens contain only non-sterile water, which can cause severe infections and sepsis after administration.\",\"source\":\"BLESK.cz\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:16:00.000Z\",\"publisher_count\":1,\"sources\":[\"BLESK.cz\"]},{\"statement\":\"Jairo Noreña, MD, former endocrinology fellow at Stanford University Medical Center in Palo Alto, California, and colleagues evaluated changes in body mass index and fracture incidence in adults with type 2 diabetes taking semaglutide, dulaglutide, or the oral weight-loss drugs phentermine/topiramate and bupropion/naltrexone.\",\"source\":\"Endocrine News\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:02:00.000Z\",\"publisher_count\":1,\"sources\":[\"Endocrine News\"]},{\"statement\":\"The study authors recommended that prospective studies be done to confirm the semaglutide bone-protective findings.\",\"source\":\"Endocrine News\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T15:02:00.000Z\",\"publisher_count\":1,\"sources\":[\"Endocrine News\"]}]", "kind": "news" }, "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature", "receipt": null, "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record", "generation_chain": { "wire": { "stream": "fountain_news", "story_id": "362785fea23e7fa5169b5df4e9e62966", "thread_id": "50fae0dded41a2fc8a826242f203e5fb", "thread_label": "Semaglutid", "novelty": "UPDATE", "content_hash": "14242d54139df858143428f627971a68b51fb07201449f1cede3e43d8318ed64", "last_published_at": "2026-09-03T00:00:00.000Z", "read_receipt": { "slice_hash": "3c9b48621f0f4218a678a2a78b9003162e3ebcd95cda7ce0fc22f0f1bf8ce383", "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDJUMjM6NTY6MDQuMDAwMDAwWiIsImlkIjoiNDRjMWNlZjRiNzMwNDIzNTFlMjkxNzZkYjVlZmI1NzciLCJ2IjoiMSJ9", "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDNUMDA6MjU6NDcuMDAwMDAwWiIsImlkIjoiYTM2MDgzM2I3OGEwNzVlMDcwNjIwOWY4NTg3MzJjNTciLCJ2IjoiMSJ9", "view": "v_fountain_news", "view_version": "1", "row_count": 100, "window_days": 3, "bytes_scanned": 12568115, "credits": 8, "price_per_100_rows": 8, "sig": "sUcYRuLW_W5cFdcYgEymoC-B3-7jOH1nimqWejs4H-wx4XQbt3CVVEjjr0LFOnce0XenVqd240i81LT074_3Bw", "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE", "signer_path": "lakehouse/data-extract/v1", "alg": "Ed25519", "signed": true } }, "written_at": "2026-09-03T06:40:55.440Z" }, "cited_facts": [ { "statement": "Fake Ozempic pens sold online may not contain the active ingredient semaglutide but could instead contain completely different chemicals.", "source": "BLESK.cz", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:16:00.000Z", "publisher_count": 1, "sources": [ "BLESK.cz" ] }, { "statement": "The Czech State Institute for Drug Control (SÚKL) warns that dangerous packaging for fake Ozempic injections has not yet appeared in official reports from licensed distributors but poses a risk from illegal online sales.", "source": "BLESK.cz", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:16:00.000Z", "publisher_count": 1, "sources": [ "BLESK.cz" ] }, { "statement": "Research presented at the ENDO 2026 conference reported that people taking semaglutide for type 2 diabetes had a lower rate of bone fractures compared with those taking other anti-obesity medications.", "source": "Endocrine News", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T15:02:00.000Z", "publisher_count": 1, "sources": [ "Endocrine News" ] }, { "statement": "The study data indicated that semaglutide treatment produced a greater reduction in body mass index and fewer fractures (794) than the control group (1045 fractures) among the type 2 diabetes patients analyzed.", "source": "Endocrine News", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T15:02:00.000Z", "publisher_count": 1, "sources": [ "Endocrine News" ] }, { "statement": "A retrospective observational cohort study was conducted on 12 adults with Prader-Willi syndrome at a UK academic hospital specialist clinic.", "source": "Frontiers", "instrument": "News", "claim_key": null, "published_at": "2026-09-03T00:00:00.000Z", "publisher_count": 1, "sources": [ "Frontiers" ] }, { "statement": "Researchers found no significant overall weight loss on semaglutide, but there was a significant stabilization of weight gain prior to treatment.", "source": "Frontiers", "instrument": "News", "claim_key": null, "published_at": "2026-09-03T00:00:00.000Z", "publisher_count": 1, "sources": [ "Frontiers" ] }, { "statement": "There was a significant decrease in hyperphagia scores from the Hyperphagia Questionnaire for Clinical Trials with a p-value of 0.003.", "source": "Frontiers", "instrument": "News", "claim_key": null, "published_at": "2026-09-03T00:00:00.000Z", "publisher_count": 1, "sources": [ "Frontiers" ] }, { "statement": "Semaglutide, a medication used for weight loss, has been introduced as a tablet in Germany, with plans for a similar launch in Austria.", "source": "DER STANDARD", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T10:00:00.000Z", "publisher_count": 1, "sources": [ "DER STANDARD" ] }, { "statement": "Historical cases of similar fake injections have resulted in insulin shock for non-diabetics, causing severe hypoglycemia, convulsions, or unconsciousness.", "source": "BLESK.cz", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:16:00.000Z", "publisher_count": 1, "sources": [ "BLESK.cz" ] }, { "statement": "Some fake injection pens contain only non-sterile water, which can cause severe infections and sepsis after administration.", "source": "BLESK.cz", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:16:00.000Z", "publisher_count": 1, "sources": [ "BLESK.cz" ] }, { "statement": "Jairo Noreña, MD, former endocrinology fellow at Stanford University Medical Center in Palo Alto, California, and colleagues evaluated changes in body mass index and fracture incidence in adults with type 2 diabetes taking semaglutide, dulaglutide, or the oral weight-loss drugs phentermine/topiramate and bupropion/naltrexone.", "source": "Endocrine News", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T15:02:00.000Z", "publisher_count": 1, "sources": [ "Endocrine News" ] }, { "statement": "The study authors recommended that prospective studies be done to confirm the semaglutide bone-protective findings.", "source": "Endocrine News", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T15:02:00.000Z", "publisher_count": 1, "sources": [ "Endocrine News" ] } ], "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true." }